- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03268720
Influence of the Immunosystem in Non-celiac Glutensensitivity (NCGS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients with gluten-sensitivity are rigourously checked for wheat allergy and celiac disease. Genotyping for DQ2/8, serological detection of celiac specific antibodies, and gastroduodenoscopy are performed. Furthermore, a skin prick test and detection of wheat specific IgE are done.
After exclusion of celiac disease and wheat allergy patients are considered as patients with NCGS.
Patients and healthy controls are asked to consume a low FODMAP diet for two weeks, followed by a 5 day washout and subsequent two week gluten-free diet.
At the beginning and the end of each diet the participants fill in questionnaires concerning Nutrition (Freiburger Nutrition protocol), psychological well-being index (PGWB), gastrointestinal symptom Rating score (GSRS), and stool consistency (Bristol stool Chart). Furthermore, stool samples are selected at each time point to determine the microbial pattern.
NCGS patients with ongoing complaints will have a second gastroduodenoscopy at the end of the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Erlangen, Germany, 91052
- Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy controls
- patients with glutensensitivity
Exclusion Criteria:
- patients with glutensensitivity but without celiac disease or wheat allergy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: healthy controls
FODMAP low diet gluten-free diet
|
2 week FODMAP low diet
2 week gluten-free diet
|
Other: NCGS patients
FODMAP low diet gluten-free diet
|
2 week FODMAP low diet
2 week gluten-free diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determination of clinical symptomatics
Time Frame: 2 weeks
|
Analysis of the improvement of clinical symptoms according to gastrointestinal symptom Rating score
|
2 weeks
|
Determination of psychological symptoms
Time Frame: 2 weeks
|
Improvement of well-being by questionnaire psychological General well-being index
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nutrition Analysis for energy intake and nutritional composition by questionnaire Freiburger Nutrition protocol
Time Frame: 2 weeks
|
Determination of nutrient intake according to questionnaire Freiburger Nutrition protocol.
The questionnaire allows the detailed determination of energy intake, carbohydrates, fatty acids, and Protein.
|
2 weeks
|
Intraepithelial lymphocytes
Time Frame: 4 weeks
|
numbers of intraepithelial lymphocytes in duodenal mucosa
|
4 weeks
|
Goblet cells
Time Frame: 4 weeks
|
numbers of Goblet cells in duodenal mucosa
|
4 weeks
|
microbiome
Time Frame: 2 weeks
|
Analysis of microbiota pattern
|
2 weeks
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Glutensensitivity
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gluten Sensitivity
-
Antonio Di SabatinoUnknownNonceliac Gluten SensitivityItaly
-
University of PalermoCompleted
-
University of Campania "Luigi Vanvitelli"Completed
-
Maastricht UniversityUniversity of Leeds; Wageningen UniversityCompletedNon-celiac Gluten SensitivityNetherlands, United Kingdom
-
Thomas Jefferson UniversityCompleted
-
Exzell Pharma Inc.UnknownNon-Celiac Gluten SensitivityCanada
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
University of AberdeenUnknownNon Coeliac Gluten SensitivityUnited Kingdom
-
University of HohenheimCompletedNon-celiac Gluten Sensitivity | Wheat IntoleranceGermany
-
University of PalermoCompletedNon-celiac Wheat Sensitivity | Non-celiac Gluten SensitivityItaly
Clinical Trials on FODMAP low diet
-
Ashok TutejaUnited States Department of DefenseUnknown
-
Beth Israel Deaconess Medical CenterEnrolling by invitation
-
Ohio State UniversityCompletedAutism Spectrum DisorderUnited States
-
University of NottinghamKing's College LondonCompletedIrritable Bowel SyndromeUnited Kingdom
-
Cantonal Hospital of St. GallenCompletedIBS - Irritable Bowel Syndrome
-
Northwestern UniversityWithdrawn
-
Taipei Veterans General Hospital, TaiwanNot yet recruitingIrritable Bowel Syndrome
-
Universitaire Ziekenhuizen KU LeuvenCompletedFunctional Dyspepsia | FODMAP DietBelgium
-
Oslo University HospitalActive, not recruitingIrritable Bowel Syndrome | Diet Modification | Celiac Disease | Gluten SensitivityNorway
-
Medical University of WarsawNutricia FoundationUnknown